Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis

Fig. 1

Key findings. 6MWD, six-minute walk distance; C/I, contraindication; dcSSc, diffuse cutaneous systemic sclerosis; ILD, interstitial lung disease; PAH, pulmonary arterial hypertension); PH, pulmonary hypertension; RHC, right heart catheter; SSc, systemic sclerosis; WHO, World Health Organization; WSPH, World Society of Pulmonary Hypertension

Back to article page